Skip to main content
. 2017 Mar 14;8(23):37080–37090. doi: 10.18632/oncotarget.16180

Table 4. Multivariate analysis of prognostic factors for matched patients.

Endpoint Factor p-value HR (95% CI)
OS T Stage 0.009 3.420 (1.365–8.569)
N Stage 0.027 2.270 (1.098–4.692)
M Stage 0.072 3.571 (0.891–14.307)
Clinical Stage 0.229 0.498 (0.160–1.551)
ECOG PS 0.128 1.596 (0.875–2.912)
Clinical Response 0.002 2.860 (1.488–5.497)
PFS ECOG PS 0.239 1.413 (0.795–2.511)
T Stage 0.042 2.083 (1.026–4.229)
N Stage 0.014 2.295 (1.184–4.450)
Clinical Stage 0.718 0.904 (0.522–1.566)
Clinical Response 0.012 2.061 (1.175–3.613)

Abbreviations: OS: overall survival; PFS: progression-free survival; HR: hazard ratio; CI: confidence interval.